文献速递脑血管病认知障碍与痴呆

血糖变异性与血管负荷、β-淀粉样蛋白、脑萎缩及认知障碍影像标记物的关联

Association of Glycemic Variability With Imaging Markers of Vascular Burden, β-Amyloid, Brain Atrophy, and Cognitive Impairment.
PubMed 文献 · Neurology · 2023-12-15

本回顾性队列研究纳入688例来自记忆门诊的无痴呆参与者,分析空腹血糖的个体内访视间变异度与严重白质高信号、β-淀粉样蛋白摄取、脑萎缩及认知障碍的关联;结果显示血糖变异性升高可预测严重白质高信号和β-淀粉样蛋白摄取增加,且两者分别部分介导血糖变异性与额叶执行功能障碍、记忆障碍的关系。

要点

  • 血糖变异性升高可预测严重白质高信号(系数1.032,95%CI 1.012-1.054,p=0.002)。
  • 血糖变异性升高可预测β-淀粉样蛋白摄取增加(系数1.005,95%CI 1.001-1.008,p=0.007)。
  • β-淀粉样蛋白摄取完全介导血糖变异性与海马体积的关系(间接效应-1.091,95%CI -2.078至-0.103)。

核心结论

  • 血糖变异性升高与血管性和阿尔茨海默病风险因素及神经退行性标记物相关,进而导致后续认知障碍。
  • 血糖变异性可被视为痴呆预防中一个潜在可修饰的风险因素。

研究设计与样本

  • 本回顾性队列研究纳入来自记忆门诊的无痴呆参与者,均具有β-淀粉样蛋白PET、脑MRI和标准化神经心理学测试,且研究期间空腹血糖检测超过两次。
  • 血糖变异性定义为空腹血糖水平的个体内访视间变异度。

主要发现

  • 在688名参与者中,平均年龄72.2岁,女性比例为51.9%。
  • 血糖变异性升高可预测严重白质高信号的存在(系数1.032,95%CI 1.012-1.054,p=0.002)。
  • 血糖变异性升高可预测β-淀粉样蛋白摄取增加(系数1.005,95%CI 1.001-1.008,p=0.007)。
  • 白质高信号和β-淀粉样蛋白摄取增加分别部分介导血糖变异性与额叶执行功能障碍(直接效应-0.319,95%CI -0.557至-0.080;间接效应-0.050,95%CI -0.091至-0.008)和记忆障碍(直接效应-0.182,95%CI -0.338至-0.026;间接效应-0.067,95%CI -0.119至-0.015)的关系。
  • β-淀粉样蛋白摄取增加完全介导血糖变异性与海马体积的关系(间接效应-1.091,95%CI -2.078至-0.103),并部分介导血糖变异性与顶叶厚度的关系(直接效应-0.00101,95%CI -0.00185至-0.00016;间接效应-0.00016,95%CI -0.00032至-0.000002)。

关键数值与推荐

  • 血糖变异性升高与严重白质高信号存在关联(系数1.032,95%CI 1.012-1.054,p=0.002)。
  • 血糖变异性升高与β-淀粉样蛋白摄取增加存在关联(系数1.005,95%CI 1.001-1.008,p=0.007)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVE: We aimed to investigate the association between glycemic variability (GV) and neuroimaging markers of white matter hyperintensities (WMH), beta-amyloid (Aβ), brain atrophy, and cognitive impairment. METHODS: This was a retrospective cohort study that included participants without dementia from a memory clinic. They all had Aβ PET, brain MRI, and standardized neuropsychological tests and had fasting glucose (FG) levels tested more than twice during the study period. We defined GV as the intraindividual visit-to-visit variability in FG levels. Multivariable linear regression and logistic regression were used to identify whether GV was associated with the presence of severe WMH and Aβ uptake with DM, mean FG levels, age, sex, hypertension, and presence of APOE4 allele as covariates. Mediation analyses were used to investigate the mediating effect of WMH and Aβ uptake on the relationship between GV and brain atrophy and cognition. RESULTS: Among the 688 participants, the mean age was 72.2 years, and the proportion of female participants was 51.9%. Increase in GV was predictive of the presence of severe WMH (coefficient [95% CI] 1.032 [1.012-1.054]; p = 0.002) and increased Aβ uptake (1.005 [1.001-1.008]; p = 0.007). Both WMH and increased Aβ uptake partially mediated the relationship between GV and frontal-executive dysfunction (GV → WMH → frontal-executive; direct effect, -0.319 [-0.557 to -0.080]; indirect effect, -0.050 [-0.091 to -0.008]) and memory dysfunction (GV → Aβ → memory; direct effect, -0.182 [-0.338 to -0.026]; indirect effect, -0.067 [-0.119 to -0.015]), respectively. In addition, increased Aβ uptake completely mediated the relationship between GV and hippocampal volume (indirect effect, -1.091 [-2.078 to -0.103]) and partially mediated the relationship between GV and parietal thickness (direct effect, -0.00101 [-0.00185 to -0.00016]; indirect effect, -0.00016 [-0.00032 to -0.000002]). DISCUSSION: Our findings suggest that increased GV is related to vascular and Alzheimer risk factors and neurodegenerative markers, which in turn leads to subsequent cognitive impairment. Furthermore, GV can be considered a potentially modifiable risk factor for dementia prevention.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Jang H, Lee S, An S, et al. Association of Glycemic Variability With Imaging Markers of Vascular Burden, β-Amyloid, Brain Atrophy, and Cognitive Impairment. Neurology. 2023. PMID: 38165363. doi:10.1212/WNL.0000000000207806

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。